CIK 0001641281 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472804636
- Phone
- 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- Open-market buys, last 90 days
- $319,000
- in 1 filing
- Open-market sales, last 90 days
- $128,281
- in 3 filings
Net +$190,719. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-18 | Nemec Sarah Senior VP, Finance and PAO | Sale | −4,077 | $3.24 | $13K | 17,082 |
| 2026-09-17 | Nemec Sarah Senior VP, Finance and PAO | Sale | −2,922 | $3.32 | $10K | 21,159 |
| 2026-09-16 | Nemec Sarah Senior VP, Finance and PAO | Sale | −843 | $3.77 | $3K | 24,081 |
| 2026-06-05 | Nemec Sarah Senior VP, Finance and PAO | Purchase | +509 | $3.88 | $2K | 1,924 |
| 2026-01-28 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +8,000 | 8,000 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +1,236 | 1,236 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −1,236 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +375 | 375 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −375 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +600 | 600 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −600 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +2,199 | 2,199 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −2,199 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +6,699 | 6,699 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −6,699 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +1,589 | 1,589 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −1,589 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +2,499 | 2,499 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Returned to the company · Employee Stock Option (Right to Buy) | −2,499 | 0 | ||
| 2025-12-12 | Nemec Sarah Senior VP, Finance and PAO | Grant or award · Employee Stock Option (Right to Buy) | +4,499 | 4,499 |
Page 1 of 2 · 31 trades